Chicago — The Foundation for Sarcoidosis Research (FSR) is proud to launch the Stand Up for Sarc Campaign this April as part of National Sarcoidosis Awareness Month. Sarcoidosis (pronounced SAR-COY-DOE-SIS) is considered a rare, inflammatory disease characterized by the formation of granulomas—tiny clumps of inflammatory cells—in one or more organs...
Latest News
CHICAGO, Ill. — The Foundation for Sarcoidosis Research (FSR) is honored to host its inaugural in-person training of FSR-GSCA Volunteer Patient Leaders from around the United States at Cleveland Clinic, the FSR Global Sarcoidosis Clinic Alliance (FSR-GSCA) Founding Member. This inaugural in-person training of FSR-GSCA Volunteer Patient Leaders has been...
MISSOULA — The American Red Cross is facing a severe blood shortage, so they’re asking you to donate if you can. On Wednesday, a blood drive took place to honor a boy whose life was saved, thanks to generous blood donors. Troy Ross was just 3-years old when he was...
FRAMINGHAM — Before he reached puberty, Dick Wyman suffered about 20 broken bones. His daughter, Christine Wyman Rossi, fractured her femur while in her mother’s womb, followed by about 20 more fractures while in her childhood. Wyman’s grandson, Jack, broke two legs when only 4 weeks old. The Wyman family...
TEMPE, Ariz. — Nearly four dozen members of the ASU fraternity, Phi Gamma Delta (FIJI), plan to shave their heads Sunday in support of the Center for Rare Childhood Disorders (the Center) at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope. The “Shave to Save” fundraiser was...
SEATTLE, WA — A blood test intended for screening for colorectal cancer in people who are of average risk and not experiencing symptoms correctly detected colorectal cancer in 83% of people confirmed to have the disease, according to a study published March 14 in the New England Journal of Medicine....
Seattle, Washington – Researchers at Fred Hutchinson Cancer Center have found that a specific subtype of a microbe commonly found in the mouth is able to travel to the gut and grow within colorectal cancer tumors. This microbe is also a culprit for driving cancer progression and leads to poorer...
The 10th annual Rare Disease Genomics Symposium, hosted by the University of Alabama at Birmingham (UAB), will showcase the latest research into rare genetic diseases and focus on next-generation genetic testing and patient empowerment, the university announced. The free in-person and virtual symposium, set for Friday, brings together researchers, doctors, and...
LONDON, England — Freeline Therapeutics today announced new clinical data from its ongoing Phase 1/2 GALILEO-1 trial of FLT201, its adeno-associated virus (AAV) gene therapy candidate for Gaucher disease, showing substantial reductions in glucosylsphinogsine (lyso-Gb1), one of the best predictors of clinical response, in patients with persistently high levels despite...
SOUTH SAN FRANCISCO, Calif. — Freenome, a biotechnology company pioneering an early cancer detection platform, today announced topline results from PREEMPT CRC, a prospective, registrational clinical study to validate its blood-based test for the early detection of colorectal cancer (CRC) among average-risk adults. In a prespecified analysis, the Freenome blood...